| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 8.05▲ | 8.05▲ | 8.05▲ | 7.91▲ | 7.59▲ |
| MA10 | 7.66▲ | 7.66▲ | 7.66▲ | 7.41▲ | 7.49▲ |
| MA20 | 7.24▲ | 7.22▲ | 7.19▲ | 7.07▲ | 7.67▲ |
| MA50 | 6.74▲ | 7.20▲ | 7.31▲ | 7.31▲ | N/A |
| MA100 | 7.03▲ | 7.51▲ | N/A | N/A | N/A |
| MA200 | N/A | N/A | N/A | N/A | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.188▲ | 0.221▲ | 0.229▲ | 0.226▲ | N/A |
| RSI | 65.417▲ | 63.085▲ | 62.815▲ | 71.842▲ | 63.528▲ |
| STOCH | 51.929 | 53.867 | 55.550 | 78.297 | 53.235 |
| WILL %R | -30.108 | -27.907 | -27.907 | -10.145▲ | -9.722▲ |
| CCI | 162.758▲ | 162.670▲ | 162.721▲ | 244.489▲ | 189.177▲ |
| ▲ RSI | $NSRX RSI(14) Crossed Above 70 | Set Alert |
| ▼ GAP | $NSRX Open Gap Down %5 | Set Alert |
| ▼ GAP | $NSRX Open Gap Down %3 | Set Alert |
| ▼ GAP | $NSRX Open Gap Down %2 | Set Alert |
| ▲ BREAK | $NSRX Price Breaks 60 Days High | Set Alert |
| ▲ BREAK | $NSRX Price Breaks 30 Days High | Set Alert |
| ▲ BREAK | $NSRX Price Breaks 20 Days High | Set Alert |
| ▲ BREAK | $NSRX Price Breaks 10 Days High | Set Alert |
|
Monday, December 22, 2025 05:29 AM
Dear Shareholders, 2025 has been a transformational year for Nasus Pharma. We’ve made considerable progress building a strong, focused company with significant clinical impact, by developing drug ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 31/12/25 | 7.21 | 9.50 | 7.21 | 9.15 | 16,700 |
| 30/12/25 | 7.20 | 7.90 | 7.17 | 7.79 | 6,652 |
| 29/12/25 | 6.91 | 7.95 | 6.91 | 7.50 | 16,044 |
| 26/12/25 | 6.70 | 7.90 | 6.69 | 7.605 | 43,425 |
| 24/12/25 | 6.40 | 7.90 | 6.40 | 7.50 | 14,700 |
| 23/12/25 | 6.87 | 7.70 | 6.60 | 7.01 | 5,165 |
| 22/12/25 | 7.25 | 7.25 | 6.70 | 7.0782 | 8,107 |
| 19/12/25 | 6.05 | 7.92 | 6.05 | 7.5755 | 6,650 |
| 18/12/25 | 6.80 | 6.80 | 6.37 | 6.37 | 950 |
| 17/12/25 | 6.40 | 6.5002 | 6.40 | 6.5002 | 486 |
|
|
||||
|
|
||||
|
|